Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Change in Receivables: 2020-2024

Historic Change in Receivables for IDEAYA Biosciences (IDYA) over the last 5 years, with Dec 2024 value amounting to -$15,000.

  • IDEAYA Biosciences' Change in Receivables rose 99.75% to -$17,000 in Q4 2024 from the same period last year, while for Dec 2024 it was -$15,000, marking a year-over-year increase of 92.23%. This contributed to the annual value of -$15,000 for FY2024, which is 92.23% up from last year.
  • According to the latest figures from FY2024, IDEAYA Biosciences' Change in Receivables is -$15,000, which was up 92.23% from -$193,000 recorded in FY2023.
  • In the past 5 years, IDEAYA Biosciences' Change in Receivables registered a high of $1.9 million during FY2020, and its lowest value of -$892,000 during FY2022.
  • Over the past 3 years, IDEAYA Biosciences' median Change in Receivables value was -$193,000 (recorded in 2023), while the average stood at -$366,667.
  • As far as peak fluctuations go, IDEAYA Biosciences' Change in Receivables slumped by 141.24% in 2021, and later surged by 92.23% in 2024.
  • Over the past 5 years, IDEAYA Biosciences' Change in Receivables (Yearly) stood at $1.9 million in 2020, then tumbled by 141.24% to -$774,000 in 2021, then declined by 15.25% to -$892,000 in 2022, then surged by 78.36% to -$193,000 in 2023, then spiked by 92.23% to -$15,000 in 2024.